Telemedicine and health tracking startup Nue Life Health raised $1.9M in additional funding from existing backers. The firm also announced free versions of its Nue app and Nue score for patients undergoing ketamine therapy. A year ago, the firm secured a $23M Series A funding round led by Obvious Ventures. - Nue Life reportedly caters to over 8,000 patients across the U.S. through its "at home" ketamine programs.
- Nue Life's treatment modalities include lozenges, intramuscular (IM), and intravenous (IV) treatments.
- The firm hired former national CMO of HCA, Dr. Frank Drummond, as its new chief medical officer.
- It intends to use the proceeds to expand its market reach.
|
